Information  X 
Enter a valid email address

Glaxosmithkline PLC Ord 25P (GSK)

Related News

01-Sep-2020 09:20 AM

Broker Forecast - Morgan Stanley issues a broker note on GlaxoSmithKline PLC

Morgan Stanley today reaffirms its underweight investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1700p (from 1725p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
12-Aug-2020 09:40 AM

Broker Forecast - UBS issues a broker note on GlaxoSmithKline PLC

UBS today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1800p (from 1920p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
31-Jul-2020 12:00 PM

Broker Forecast - DZ Bank issues a broker note on GlaxoSmithKline PLC

DZ Bank today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1850p (from 1900p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
31-Jul-2020 11:50 AM

Broker Forecast - Goldman Sachs issues a broker note on GlaxoSmithKline PLC

Goldman Sachs today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 2020p (from 2060p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
31-Jul-2020 08:10 AM

Broker Forecast - Credit Suisse issues a broker note on GlaxoSmithKline PLC

Credit Suisse today reaffirms its neutral investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1700p (from 1860p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
29-Jul-2020 01:22 PM

GlaxoSmithKline adjusted earnings slump on lower vaccine sales

Pharmaceutical company GlaxoSmithKline said that meeting its annual earnings guidance was contingent on the timing of a recovery in vaccine demand, a slump in which drove a fall in its second-quarter sales. The company reported a more than doubling in pr
22-Jun-2020 12:10 PM

Broker Forecast - Oddo issues a broker note on GlaxoSmithKline PLC

Oddo today reaffirms its neutral investment rating on GlaxoSmithKline PLC (LON:GSK) and raised its price target to 1840p (from 1760p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
14-May-2020 10:10 AM

Broker Forecast - UBS issues a broker note on GlaxoSmithKline PLC

UBS today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and raised its price target to 1920p (from 1900p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
05-May-2020 10:30 AM

Broker Forecast - JP Morgan Cazenove issues a broker note on GlaxoSmithKline PLC

JP Morgan Cazenove today reaffirms its neutral investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1700p (from 1750p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
04-May-2020 12:30 PM

Broker Forecast - Goldman Sachs issues a broker note on GlaxoSmithKline PLC

Goldman Sachs today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and raised its price target to 2060p (from 1900p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
01-May-2020 03:40 PM

Broker Forecast - DZ Bank issues a broker note on GlaxoSmithKline PLC

DZ Bank today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and raised its price target to 1950p (from 1900p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
30-Apr-2020 11:30 AM

Broker Forecast - Barclays Capital issues a broker note on GlaxoSmithKline PLC

Barclays Capital today reaffirms its underweight investment rating on GlaxoSmithKline PLC (LON:GSK) and raised its price target to 1550p (from 1450p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
29-Apr-2020 01:15 PM

GlaxoSmithKline earnings jump 41% amid Covid-19 drug stockpiling

Pharmaceutical company GlaxoSmithKline posted a 41% jump in first-quarter earnings after drug sales were boosted by stockpiling amid the Covid-19 pandemic. Operating profit for the three months through March increased to £2.01bn, as revenue rose 19
31-Mar-2020 11:20 AM

Broker Forecast - Oddo issues a broker note on GlaxoSmithKline PLC

Oddo today reaffirms its neutral investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1530p (from 1830p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
17-Mar-2020 08:40 AM

Broker Forecast - Barclays Capital issues a broker note on GlaxoSmithKline PLC

Barclays Capital today reaffirms its underweight investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1450p (from 1550p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
03-Mar-2020 11:40 AM

Broker Forecast - Morgan Stanley issues a broker note on GlaxoSmithKline PLC

Morgan Stanley today reaffirms its underweight investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1725p (from 1740p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
18-Feb-2020 08:30 AM

Broker Forecast - Liberum Capital issues a broker note on GlaxoSmithKline PLC

Liberum Capital today reaffirms its hold investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1840p (from 1930p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
13-Feb-2020 10:30 AM

Broker Forecast - Societe Generale issues a broker note on GlaxoSmithKline PLC

Societe Generale today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 2240p (from 2300p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
13-Feb-2020 10:20 AM

Broker Forecast - HSBC issues a broker note on GlaxoSmithKline PLC

HSBC today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 2050p (from 2110p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
11-Feb-2020 10:30 AM

Broker Forecast - UBS issues a broker note on GlaxoSmithKline PLC

UBS today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1900p (from 1950p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
11-Feb-2020 09:50 AM

Broker Forecast - JP Morgan Cazenove issues a broker note on GlaxoSmithKline PLC

JP Morgan Cazenove today reaffirms its neutral investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1750p (from 1900p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
10-Feb-2020 08:20 AM

Broker Forecast - Deutsche Bank issues a broker note on GlaxoSmithKline PLC

Deutsche Bank today reaffirms its hold investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1600p (from 1650p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
07-Feb-2020 10:50 AM

Broker Forecast - Barclays Capital issues a broker note on GlaxoSmithKline PLC

Barclays Capital today reaffirms its underweight investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1550p (from 1650p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
06-Feb-2020 11:00 AM

Broker Forecast - Bryan Garnier issues a broker note on GlaxoSmithKline PLC

Bryan Garnier today reaffirms its neutral investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1773p (from 1800p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
05-Feb-2020 01:14 PM

GlaxoSmithKline profit rises 30%; forecasts weaker earnings in 2020

Pharmaceutical company GlaxoSmithKline reported a 30% rise in annual profit after it doubled of sales of its shingles vaccine, though if forecast weaker earnings in 2020. Pre-tax profit for the year through December roes to £6.22bn, up from £
 
Headlines
Top categories
Company finder

a d v e r t i s e m e n t